Biotechnology company and drug delivery platform
innovator Lexaria Bioscience
Corp. (CSE: LXX) (OTCQX: LXRP)today announced its entry into a definitive
5-year agreement, via its subsidiary Lexaria Hemp Corp, with Nic’s Beverages
L.L.C. Under the agreement, Lexaria will provide its patented DehydraTECH(TM)
technology for use in Nic’s CBD-based beverages to be produced and sold
throughout the United States. According to the update, Nic’s Beverages will initially
begin production of ready-to-drink cold brew coffees enhanced with CBD from
multi spectrum hemp oil. “We are currently in discussions with major wholesale
houses and are looking to be in the market by the first of October,” Nic’s
Beverages CEO John Goodpasture said in the news release. “DehydraTECH
technology is perfect in allowing us to deliver CBD from hemp oil with zero
impact on our cold brewed coffee’s outstanding aroma or flavour. Nic’s is
extremely excited about our new product lines and our continued growth with
Lexaria.”
To view the full press releases, visit http://ibn.fm/hP4mJ
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented
delivery technology that promotes healthier ingestion methods, lower overall
dosing and higher effectiveness of lipophilic active molecules. Lexaria has
multiple patents pending in over 40 countries around the world and has patents
granted in the USA and in Australia for utilization of its DehydraTECH(TM)
delivery technology. Lexaria’s technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important
taste-masking benefits, for orally administered bioactive molecules including
cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),
nicotine and other molecules. For more information, visit the company’s website
at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates
relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
